Promethera Biosciences inks funding
Promethera Biosciences, a Belgian liver therapeutics company, has secured 7.5 million euros in funding.
Promethera Biosciences, a Belgian liver therapeutics company, has secured 7.5 million euros in funding.
Copyright PEI Media
Not for publication, email or dissemination